---
{"dg-publish":true,"permalink":"/research/takeaways/2025-01-30-12-16-01/","updated":"2025-02-03T16:34:35-05:00"}
---

# Content
- [[Research/Tags/Back Pain\|Back Pain]] in the [[Research/Tags/Lumbar Spine\|Lumbar Spine]] can be reduced within 3 months after injection of 10±5 million [[Research/Tags/Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)\|Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)]] into a non-torn [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] at [[Research/Tags/L5-S1\|L5-S1]], [[Research/Tags/L4-L5\|L4-L5]], or both levels
# References
<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Insights</span><span class="dataview small-text">3</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 12-15-27.md" data-href="Research/Insights/2025-01-30 12-15-27.md" href="Research/Insights/2025-01-30 12-15-27.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 12-15-27</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Back Pain" href="Back Pain" class="internal-link" target="_blank" rel="noopener nofollow">Back Pain</a> in the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a> is reduced by an average of 71% at 12 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 12-13-47.md" data-href="Research/Insights/2025-01-30 12-13-47.md" href="Research/Insights/2025-01-30 12-13-47.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 12-13-47</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Back Pain" href="Back Pain" class="internal-link" target="_blank" rel="noopener nofollow">Back Pain</a> in the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a> is reduced by an average of 69% at 6 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 12-11-56.md" data-href="Research/Insights/2025-01-30 12-11-56.md" href="Research/Insights/2025-01-30 12-11-56.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 12-11-56</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Back Pain" href="Back Pain" class="internal-link" target="_blank" rel="noopener nofollow">Back Pain</a> in the <a data-href="Lumbar Spine" href="Lumbar Spine" class="internal-link" target="_blank" rel="noopener nofollow">Lumbar Spine</a> is reduced by an average of 62% at 3 months after injection of 10±5 million <a data-href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" href="Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)" class="internal-link" target="_blank" rel="noopener nofollow">Normoxic-Cultured Autologous Mesenchymal Stem Cells (MSCs)</a> into a non-torn <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> at <a data-href="L5-S1" href="L5-S1" class="internal-link" target="_blank" rel="noopener nofollow">L5-S1</a>, <a data-href="L4-L5" href="L4-L5" class="internal-link" target="_blank" rel="noopener nofollow">L4-L5</a>, or both levels</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Original Sources</span><span class="dataview small-text">1</span></th><th class="table-view-th"><span>Citations</span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Evidence Sources/orozcoIntervertebralDiscRepair2011.md" data-href="Research/Evidence Sources/orozcoIntervertebralDiscRepair2011.md" href="Research/Evidence Sources/orozcoIntervertebralDiscRepair2011.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">orozcoIntervertebralDiscRepair2011</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Orozco, Lluis, Robert Soler, Carles Morera, Mercedes Alberca, Ana Sánchez, and Javier García-Sancho. “Intervertebral Disc Repair by Autologous Mesenchymal Bone Marrow Cells: A Pilot Study.” Transplantation 92, no. 7 (October 15, 2011): 822–28. <a rel="noopener nofollow" class="external-link" href="https://doi.org/10.1097/TP.0b013e3182298a15" target="_blank">https://doi.org/10.1097/TP.0b013e3182298a15</a>.</span></td></tr></tbody></table></div>

